Related Experiment Video
Updated: Aug 8, 2026

12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Heparin after acute myocardial infarction
1Department of Medicine, Groote Schuur Hospital, Cape Town, South Africa.
Cardiovascular Drugs and Therapy
|April 1, 1997
Summary
The role of heparin after acute myocardial infarction is unclear. Evidence does not consistently support its use with aspirin or thrombolytic therapy, and potential risks exist.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heparin is frequently used post-acute myocardial infarction, but its administration varies.
- Its use alongside aspirin and thrombolytics requires further investigation.
Purpose of the Study:
- To review the role of heparin in acute myocardial infarction management.
- To assess heparin's efficacy when combined with aspirin and thrombolytic agents.
Main Methods:
- Literature review focusing on heparin's use in acute myocardial infarction.
- Analysis of studies involving heparin, aspirin, and thrombolytic therapy.
Main Results:
- Intravenous heparin post-thrombolysis with aspirin is untested.
- Benefits of heparin are observed within a narrow activated partial thromboplastin time (aPTT) range; excessive effect linked to increased mortality.
- Delayed subcutaneous heparin with aspirin and thrombolytics shows no mortality benefit.
- No clear mortality benefit for heparin in patients on aspirin without thrombolysis.
- Heparin may reduce intraventricular thrombus but not cerebral embolism or stroke.
Conclusions:
- Heparin's role in acute myocardial infarction management remains uncertain due to unclear benefits and increased bleeding risks.
- Further research is needed to clarify optimal heparin use in specific patient populations.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

